FMZNF yields 625.00% · PFE yields 6.13%● Live data
📍 FMZNF pulled ahead of the other in Year 1
Combined, FMZNF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of FMZNF + PFE for your $10,000?
Qoria Limited markets, distributes, and sells cyber safety products and services. It offers Family Zone platform that delivers cyber safety settings, advice, and support to parents and schools across various networks and devices to keep children safe at home and school, as well as permits telecommunication service providers and device manufacturers to embed cyber safety practices into their offerings. The company also provides classroom management solutions. It offers hot spotting, VPN, and mobile solutions for families and schools, IT companies, educators, residential managers, and pastoral care organizations. It serves in Australia, New Zealand, the United Kingdom, the United States, Europe, Canada, Asia, and internationally. The company was formerly known as Family Zone Cyber Safety Limited and changed its name to Qoria Limited in May 2023. Qoria Limited was incorporated in 2014 and is based in Perth, Australia.
Full FMZNF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.